Prevalence and Association of Dysfunctional Breathing With Nicotine Dependence and Physical Activity Among Young Smokers
Prevalence of Dysfunctional Breathing and Its Association With Nicotine Dependence and Physical Activity Level Among Young Smokers: A Cross-Sectional Study
We will structure the study's summary to provide a clear and accessible overview for patients, families, and healthcare providers. The research will examine young adult cigarette smokers aged 18 to 24 to estimate the prevalence of a dysfunctional breathing-compatible symptom pattern using the Nijmegen Questionnaire. Furthermore, the study will assess how nicotine dependence severity-measured via the Fagerström Test for Nicotine Dependence-and physical activity levels-assessed using the International Physical Activity Questionnaire-relate to this symptom burden. We will recruit participants through social media announcements and conduct face-to-face evaluations at Istinye University. The project will employ hierarchical linear and binary logistic regression models, adjusting for age, sex, and body mass index, to determine independent predictors of dysfunctional breathing. Ultimately, the findings will provide valuable insights into the combined impacts of smoking severity and physical activity on respiratory health in young adults.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
The study population will consist of young adult cigarette smokers aged 18 to 24 recruited through social media announcements, who will undergo face-to-face evaluation and eligibility assessments at a single center.
La description
Inclusion Criteria:
- Being between 18 and 24 years of age.
- Reporting current cigarette smoking (daily or occasionally) at the time of assessment
Exclusion Criteria:
- Having a diagnosed personality disorder.
- Having a substance use disorder.
- Engaging in regular meditation or breathing exercises.
- Having a chronic cardiovascular or pulmonary disease.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: OTHER
- Perspectives temporelles: CROSS_SECTIONAL
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Young adult cigarette smokers.
|
This study will not involve any experimental medical treatment or intervention. It will be an observational evaluation where participants will complete self-report instruments, including the Fagerström Test for Nicotine Dependence, the International Physical Activity Questionnaire, and the Nijmegen Questionnaire, along with a sociodemographic form during a single face-to-face session. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Fagerström Test for Nicotine Dependence
Délai: Measured once during the single face-to-face evaluation session
|
his instrument will assess the severity of nicotine dependence through six items evaluating daily cigarette consumption and smoking patterns. |
Measured once during the single face-to-face evaluation session
|
|
Nijmegen Questionnaire
Délai: Measured once during the single face-to-face evaluation session.
|
This questionnaire will assess the symptom burden of respiratory, neurovegetative, and neuromuscular features to identify a dysfunctional breathing-compatible symptom pattern. |
Measured once during the single face-to-face evaluation session.
|
|
International Physical Activity Questionnaire Short Form
Délai: Measured once during the single face-to-face evaluation session.
|
This tool will evaluate the participant's physical activity levels over the previous week by recording the duration and frequency of walking and physical activities. |
Measured once during the single face-to-face evaluation session.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 125
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .